King-Jen Chang
Overview
Explore the profile of King-Jen Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
3898
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tai H, Chen K, Wu M, Chang K, Chen C, Chen A
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884818
For ultrasound imaging of thyroid nodules, medical guidelines are all based on findings of sonographic features to provide clinicians management recommendations. Due to the recent development of artificial intelligence and...
2.
Lin P, Chen S, Tseng L, Chang K, Huang A, Cheng K, et al.
Breast Cancer Res Treat
. 2022 Feb;
192(3):629-637.
PMID: 35113257
Purpose: Breast cancer is increasing around the globe, including Asia. We aimed to examine the survival and risk of contralateral breast cancer (CBC) in Asian breast cancer patients with BRCA...
3.
Wu C, Hsieh C, Chang Y, Huang C, Yeh H, Hou M, et al.
Commun Biol
. 2021 Sep;
4(1):1052.
PMID: 34504292
Whole-genome doubling (WGD) is an early macro-evolutionary event in tumorigenesis, involving the doubling of an entire chromosome complement. However, its impact on breast cancer subtypes remains unclear. Here, we performed...
4.
Chen C, Lai C, Luh D, Chuang S, Yang K, Yeh Y, et al.
J Formos Med Assoc
. 2021 Jun;
120 Suppl 1:S6-S18.
PMID: 34116896
The spread of the emerging pathogen, named as SARS-CoV-2, has led to an unprecedented COVID-19 pandemic since 1918 influenza pandemic. This review first sheds light on the similarity on global...
5.
Chang W, Chen Y, Hsu C, Chen C, Chen S, Chang K
J Formos Med Assoc
. 2021 Jun;
120 Suppl 1:S69-S76.
PMID: 34116895
Background: Cumulative data of case-fatality rates (CFR) of COVID-19 varied across countries. A forecasting model generated based on detailed information from three countries during the initial phase of pandemic showed...
6.
Wu C, Yeh H, Hsieh C, Huang C, Chattopadhyay A, Chung Y, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33920370
The evolutionary trajectories that drive clinical and therapeutic consequences in localized breast cancers (BCs) with ipsilateral breast tumor relapse (IBTR) remain largely unknown. Analyses of longitudinal paired whole-exome sequencing data...
7.
Midha M, Huang Y, Yang H, Fan T, Chang N, Chen T, et al.
Cancers (Basel)
. 2020 Aug;
12(8).
PMID: 32731431
Early onset breast cancer (EOBC), diagnosed at age ~40 or younger, is associated with a poorer prognosis and higher mortality rate compared to breast cancer diagnosed at age 50 or...
8.
Chiu L, Kuo W, Chen C, Chang K, Chen A
J Ultrasound Med
. 2020 Jun;
39(12):2439-2455.
PMID: 32567133
Objectives: The role of image analysis in 3-dimensional (3D) automated breast ultrasound (ABUS) images is increasingly important because of its widespread use as a screening tool in whole-breast examinations. However,...
9.
Chung Y, Chiu H, Wei W, Chang K, Chao W
Eur J Clin Invest
. 2020 May;
:e13255.
PMID: 32350854
Background: Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate (ADC) for the treatment of human epidermal growth factor receptor 2 (HER-2)-positive breast cancer. T-DM1 is based on the trastuzumab antibody and...
10.
Hou I, Lin H, Shen S, Chang K, Tai H, Tsai A, et al.
JMIR Mhealth Uhealth
. 2020 Mar;
8(3):e17084.
PMID: 32130181
Background: There are over 2 million newly diagnosed patients with breast cancer worldwide with more than 10,000 cases in Taiwan each year. During 2017-2018, the National Yang-Ming University, the Taiwan...